Prognosis and severity of myelin oligodendrocyte glycoprotein-immunoglobulin G-related diseases

Ichiro Nakashima

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

Myelin oligodendrocyte glycoprotein-immunoglobulin G-related demyelinating disease is part of a relatively new disease spectrum that differs from multiple sclerosis. A recent European study showed that adult onset myelin oligodendrocyte glycoprotein-immunoglobulin G-related demyelinating disease might have frequent relapses and a poor prognosis similar to anti-aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders.

Original languageEnglish
Pages (from-to)105-106
Number of pages2
JournalClinical and Experimental Neuroimmunology
Volume8
Issue number2
DOIs
Publication statusPublished - 2017 May 1

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Immunology
  • Immunology and Microbiology (miscellaneous)
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Prognosis and severity of myelin oligodendrocyte glycoprotein-immunoglobulin G-related diseases'. Together they form a unique fingerprint.

Cite this